Decoding therapy resistance in liver tumours: a giant leap

Chantal Desdouets; Amaia Lujambio

doi:10.1038/s41575-021-00550-1

Decoding therapy resistance in liver tumours: a giant leap

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	83-84
Number of pages	2
Journal	Nature Reviews Gastroenterology and Hepatology
Volume	19
Issue number	2
DOIs	https://doi.org/10.1038/s41575-021-00550-1
State	Published - Feb 2022

Access to Document

10.1038/s41575-021-00550-1

Cite this

@article{ee0b701ca06b4c7a8080a8314ae204bc,

title = "Decoding therapy resistance in liver tumours: a giant leap",

author = "Chantal Desdouets and Amaia Lujambio",

note = "Funding Information: A.L. has received consulting fees from AstraZeneca and research funding from Genentech and Pfizer. C.D. declares no competing interests.",

year = "2022",

month = feb,

doi = "10.1038/s41575-021-00550-1",

language = "English",

volume = "19",

pages = "83--84",

journal = "Nature Reviews Gastroenterology and Hepatology",

issn = "1759-5045",

publisher = "Nature Research",

number = "2",

}

TY - JOUR

T1 - Decoding therapy resistance in liver tumours

T2 - a giant leap

AU - Desdouets, Chantal

AU - Lujambio, Amaia

N1 - Funding Information: A.L. has received consulting fees from AstraZeneca and research funding from Genentech and Pfizer. C.D. declares no competing interests.

PY - 2022/2

Y1 - 2022/2

UR - https://www.scopus.com/pages/publications/85118834120

U2 - 10.1038/s41575-021-00550-1

DO - 10.1038/s41575-021-00550-1

M3 - Comment/debate

C2 - 34750549

AN - SCOPUS:85118834120

SN - 1759-5045

VL - 19

SP - 83

EP - 84

JO - Nature Reviews Gastroenterology and Hepatology

JF - Nature Reviews Gastroenterology and Hepatology

IS - 2

ER -